A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 11/02 (2006.01)
Patent
CA 2724277
The present invention relates generally to the use of recombinant human CC10 (rhCC10), also known as recombi-nant human uteroglobin, for use as a therapeutic in the treatment of nasal rhinitis, nasal sinusitis, chronic rhinosinusitis, and nasal polyposis. More particularly, the invention provides methods, including broadly the critical dosage ranges of rhCC10 and in-tranasal route of administration, which may be administered to safely and effectively treat the aforementioned conditions. The in-vention further provides a composition useful in administering rhCC10 to humans.
La présente invention concerne de façon générale lutilisation de la protéine recombinée humaine CC10 (rhCC10), également connue sous le nom dutéroglobine recombinée humaine, comme agent thérapeutique dans le traitement de la rhinite nasale, de la sinusite nasale, de la rhinosinusite chronique, et de la polypose nasale. Plus particulièrement, linvention concerne des procédés, y compris, globalement, les gammes posologiques critiques de rhCC10 et la voie dadministration intranasale, qui peuvent être utilisés pour traiter de façon sûre et efficace les pathologies susmentionnées. Linvention concerne en outre une composition utile pour ladministration de rhCC10 à des humains.
Pilon Aprile L.
Clarassance Inc.
Ridout & Maybee Llp
LandOfFree
Recombinant human cc10 and compositions thereof for use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant human cc10 and compositions thereof for use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant human cc10 and compositions thereof for use in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1983921